CD79A and rheumatoid arthritis: As previously reported (9, 12), KTRs failed to develop IgA and IgG anti-vaccine including neutralizing titres, while in the RA and the RTX group, the titre of neutralizing antibodies were significantly diminished upon vaccination (Figure 1A).